| Bumetanide Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Bumetanide 1 mg | tablet | oral | 1.0 each | OTC |
| Bumetanide 0.5 mg | tablet | oral | 1.0 each | OTC |
| Bumetanide 2 mg | tablet | oral | 1.0 each | OTC |
| Bumetanide 0.25 mg/mL | solution | injectable | 1.0 milliliter(s) | OTC |
| Bumetanide - | powder | compounding | 100.0 gram(s) | OTC |
Posted by ejbell over 5 years ago
About 1 week ago I started taking a 1mg bumetanide tablet daily,also a 400mg magnesium oxide tablet daily. I have developed...
China Biopharma Investing Looks Good for 2008 - Seeking Alpha
OB) was granted SFDA approval for a generic version of Bumetanide injection, a diuretic (see story). As an observation with far-ranging implications, ...
Mon Feb 04 07:03:28 -0500 2008
Helpson Biopharma gets SFDA approval for generic diuretic - Interfax.cn (subscription)
... to market a generic version of bumetanide injection, a diuretic, on the country's market, an official with China Pharma Holdings told Interfax today. ...
Fri Feb 01 03:07:36 -0500 2008
China's FDA Shapes Up: Good News for China Pharma, Aida, Sinobiomed - Seeking Alpha
OB) announced that its generic Bumetanide injection product has received approval. Bumetanide is a diuretic used for the treatment of cardiovascular and ...
Thu Jan 31 10:43:15 -0500 2008
bumetanide - A synthetic butylamino-sulfamoylbenzoic acid derivative, Bumetanide is a loop diuretic that inhibits sodium reabsorption in the ascending limb of the loop of Henle; potassium excretion is increased in a dose-related fashion. Bumetanide is used for edema associated with congestive heart failure, cirrhosis, and nephrotic syndrome. (NCI04)